Chromatin, nuclear matrix and the cytoskeleton: Role of cell structure in neoplastic transformation (review)

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 827-837

  Holth, Laurel T ^a   Chadee, Deborah N ^a   Spencer, Virginia A ^a   Samuel, Shanti K ^a   Safneck, Janice R ^b   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Chromatin structure; Cytoskeleton; Histone acetylation and phosphorylation; Intermediate filaments; Nuclear matrix; Oncogene transformed fibroblasts

Indexed keywords

HISTONE;

ACETYLATION; CELL NUCLEUS MATRIX; CELL STRUCTURE; CHROMATIN STRUCTURE; CYTOSKELETON; HUMAN; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031718304     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.827     Document Type: Review

References (169)

1. Laitinen J, Sistonen L, Alitalo K and Holtta E: c-Ha-ras (val 12) oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts. J Cell Biol 111:9-17, 1990.
2. Leavitt J, Bushar G, Kakunaga T, Hamada H, Hirakawa T, Goldman D and Merril C: Variations in expression of mutant β actin accompanying incremental increases in human fibroblast tumorigenicity. Cell 28: 259-268, 1982.
3. Matsumura F, Lin JJ, Yamashiro-Matsumura S, Thomas GP and Topp WC: Differential expression of tropomyosin forms in the microfilaments isolated from normal and transformed rat cultured cells. J Biol Chem 258: 13954-13964, 1983.
4. Pollack R; Osborn M and Weber K: Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Natl Acad Sci USA 72: 994-998, 1975.
5. White E and Cipriani R: Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol Cell Biol 10: 120-130, 1990.
6. Brancolini C and Schneider C: Change in the expression of a nuclear matrix-associated protein is correlated with cellular transformation. Proc Natl Acad Sci USA 88: 6936-6940, 1991.
7. Penman S: Rethinking cell structure. Proc Natl Acad Sci USA 92:5251-5257, 1995.
8. Maniotis AJ, Chen CS and Ingber DE: Demonstration of mechanical connections between integrins, cytoskeleton filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 94: 849-854, 1997.
9. Bode J, Schlake T, Rios-Ramirez M, Mielke C, Stengert M, Kay V and Klehr-Wirth D: Scaffold matrix-attached regions: structural properties creating transcriptionally active loci. Int Rev Cytol 162A: 389-454, 1995.
10. Davie JR: The nuclear matrix and the regulation of chromatin organization and function. Int Rev Cytol 162A: 191-250, 1995.
11. Ingber DE, Dike L, Hansen L, Karp S, Liley H, Maniotis A, McNamee H, Mooney D, Plopper G, Sims J and Wang N: Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol 150: 173-224, 1994.
12. Getzenberg RH, Pienta KJ, Ward WS and Coffey DS: Nuclear structure and the three-dimensional organization of DNA. J Cell Biochem 47: 289-299, 1991.
13. Maniotis AJ, Bojanowski K and Ingber DE: Mechanical continuity and reversible chromosome disassembly within intact genomes removed from living cells. J Cell Biochem 65: 114-130, 1997.
14. Barboro P, Alberti I, Sanna P, Parodi S, Balbi C, Allera C and Patrone E: Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation. Exp Cell Res 225: 315-327, 1996.
15. Benecke B-J, Ben-Ze'ev A and Penman S: The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts. Cell 14:931-939, 1978.
16. Gospodarowicz D, Greenburg G and Birdwell CR: Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth. Cancer Res 38:4155-4171, 1978.
17. Boudreau N, Myers C and Bissell MJ: From laminin to lamin: regulation of tissue-specific gene expression by the ECM Trends Cell Biol 5: 1-4, 1995.
18. Myers CA, Schmidhauser C, Mellentin-Michclotti J, Fragoso G, Roskelley CD, Casperson G, Mossi R, Pujuguet P, Hager G and Bissell MJ: Characterization of BCE-I, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol Cell Biol 18: 2184-2195, 1998.
19. Davie JR: Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol Biol Rep 24: 197-207, 1997.
20. Davie JR: Covalent modifications of histones: expression from chromatin templates. Curr Opin Genet Dev 8: 173-178, 1998.
21. Allred DC, O'Connell P and Fuqua SAW: Biomarkers in early breast neoplasia. J Cell Biochem 17G: 125-131, 1993.
22. Pienta KJ and Coffey DS: Correlation of nuclear morphometry with progression of breast cancer. Cancer 68: 2012-2016, 1991.
23. Komitowski DD, Hart MM and Janson CP: Chromatin organization and breast cancer prognosis: two-dimensional and three-dimensional image analysis. Cancer 72: 1239-1246, 1993.
24. DePinho RA: Transcriptional repression. The cancer-chromatin connection. Nature 391: 533-536, 1998.
25. Parseghian MH, Henschen AH, Krieglstein KG and Hamkalo BA: A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. Protein Sci 3: 575-587, 1994.
26. Tse C and Hansen JC: Hybrid trypsinized nucleosomal arrays: identification of multiple functional roles of the H2A/H2B and H3/H4 N-termini in chromatin fiber compaction. Biochemistry 36: 11381-11388, 1997.
27. Garcia Ramirez M, Dong F and Ausio J: Role of the histone 'tails' in the folding of oligonucleosomes depleted of histone H1. J Biol Chem 267:19587-19595, 1992.
28. Van Holde K and Zlatanova J: What determines the folding of the chromatin fiber? Proc Natl Acad Sci USA 93: 10548-10555, 1996.
29. Shen X and Gorovsky MA: Linker histone H1 regulates specific gene expression but not global transcription in vivo. Cell 86: 475-483, 1996.
30. Kaludov NK, Pabon-Pena L, Seavy M, Robinson G and Hurt MM: A mouse histone H1 variant, H1b, binds preferentially to a regulatory sequence within a mouse H3.2 replication-dependent histone gene. J Biol Chem 272: 15120-15127, 1997.
31. Hansen JC: The core histone amino-termini: combinatorial interaction domains that link chromatin structure with function. Chemtracts: Biochem Mol Biol 10: 56-69, 1997.
32. Van Holde KE: Chromatin. Rich A (ed). Springer-Verlag, New York, 1988.
33. Edmondson DG, Smith MM and Roth SY: Repression domain of the yeast global repressor Tupl interacts directly with histones H3 and H4. Genes Dev 10: 1247-1259, 1996.
34. Palaparti A, Baratz A and Stifani S: The Groucho/transducin-like enhancer of split transcriptional repressors interact with the genetically defined amino-terminal silencing domain of histone H3. J Biol Chem 272: 26604-26610, 1997.
35. Trieschmann L, Martin B and Bustin M: The chromatin unfolding domain of chromosomal protein HMG-14 targets the N-terminal tail of histone H3 in nucleosomes. Proc Natl Acad Sci USA 95: 5468-5473, 1998.
36. Parkhurst SM: Groucho: making its Marx as a transcriptional co-repressor. Trends Genet 14: 130-132, 1998.
37. Nightingale KP, Wellinger RE, Sogo JM and Becker PB: Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin. EMBO J 17: 2865-2876, 1998.
38. Czarnota GJ, Bazett-Jones DP, Mendez E, Allfrey VG and Ottensmeyer FP: High resolution microanalysis and three-dimensional nucleosome structure associated with transcribing chromatin. Micron 28: 419-431, 1997.
39. Walia H, Chen HY, Sun J-M, Holth LT and Davie JR: Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. J Biol Chem 273: 14516-14522, 1998.
40. Ridsdale JA, Hendzel MJ, Delcuve GP and Davie JR: Histone acetylation alters the capacity of the HI histones to condense transcriptionally active/competent chromatin. J Biol Chem 265: 5150-5156, 1990.
41. Garcia-Ramirez M, Rocchini C and Ausio J: Modulation of chromatin folding by histone acctylation. J Biol Chem 270: 17923-17928, 1995.
42. Tse C, Sera T, Wolffe AP and Hansen JC: Disruption of higher order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol (In press).
43. Krajewski WA and Becker PB: Reconstitution of hyperacetylated, DNase I-sensitive chromatin characterized by high conformational flexibility of nucleosomal DNA. Proc Natl Acad Sci USA 95: 1540-1545, 1998.
44. Samuel SK, Spencer VA, Bajno L, Sun J-M, Holth LT, Oesterreich S and Davie JR: In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells. Cancer Res (In press).
45. De Belle I, Cai S and Kohwi-Shigematsu T: The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops. J Cell Biol 141:335-348, 1998.
46. Bode J, Stengert-Iber M, Kay V, Schlake T and Dietz-Pfeilstetter A: Scaffold/matrix-attached regions: topological switches with multiple regulatory functions. Crit Rev Eukaryot Gene Expr 6: 115-138, 1996.
47. Benham C, Kohwi-Shigematsu T and Bode J: Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J Mol Biol 274: 181-196, 1997.
48. Boulikas T: Chromatin domains and prediction of MAR sequences. Int Rev Cytol 162A: 279-388, 1995.
49. Stein GS, Lian JB, van Wijnen AJ and Stein JL: The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol Biol Rep 24: 185-196, 1997.
50. Jackson DA: Chromatin domains and nuclear compartments: establishing sites of gene expression in eukaryotic nuclei. Mol Biol Rep 24: 209-220, 1997.
51. McNeil S, Gou B, Stein JL, Lian JB, Bushmeyer S, Seto E, Atchison ML, Penman S, van Wijnen AJ and Stein GS: Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem 68: 500-510, 1998.
52. Ingber DE: Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci 104: 613-627, 1993.
53. Georgatos SD and Maison C: Integration of intermediate filaments into cellular organelles. Int Rev Cytol 164: 91-138, 1996.
54. Nickerson JA, Krockmalnic G, He DC and Penman S: Immunolocalization in three dimensions: immunogold staining of cytoskeletal and nuclear matrix proteins in resinless electron microscopy sections. Proc Natl Acad Sci USA 87: 2259-2263, 1990.
55. Ward WS, Schmidt WN, Schmidt CA and Hnilica LS: Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc Natl Acad Sci USA 81: 419-423, 1984.
56. Wang X, Tolstonog G, Shoeman RL and Traub P: Selective binding of specific mouse genomic DNA fragments by mouse vimentin filaments in vitro. DNA Cell Biol 15: 209-225, 1996.
57. Olinski R, Wedrychowski A, Schmidt WN, Briggs RC and Hnilica LS: In vivo DNA-protein cross-linking by cis- and trans-diamminedichloroplatinum(II). Cancer Res 47: 201-205, 1987.
58. Ferraro A, Grandi P, Eufemi M, Altieri F and Turano C: Crosslinking of nuclear proteins to DNA by cis-diammine-dichloroplatinum in intact cells. Involvement of nuclear matrix proteins. FEBS Lett 307: 383-385, 1992.
59. Hartig R, Huang Y, Janetzko A, Shoeman R, Grub S and Traub P: Binding of fluorescence- and gold-labeled oligodeoxyribo-nucleotides to cytoplasmic intermediate filaments in epithelial and fibroblast cells. Exp Cell Res 233: 169-186, 1997.
60. Oshima RG, Baribault H and Caulin C: Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 15: 445-471, 1996.
61. Trask DK, Band V, Zajchowski DA, Yaswen P, Suh T and Sager R: Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA 87: 2319-2323, 1990.
62. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR and Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544, 1992.
63. Sommers CL, Walker RL, Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S and Gelmann EP: Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49: 4258-4263, 1989.
64. Andreoli JM and Trevor KT: Structural and biological consequences of increased vimentin expression in simple epithelial cell types. Cell Motil Cytoskeleton 32: 10-25, 1995.
65. Hendrix MJ, Seftor EA, Seftor RE and Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150: 483-495, 1997.
66. Pankov R, Umezawa A, Maki R, Der CJ, Hauser CA and Oshima RG: Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci USA 91: 873-877, 1994.
67. Cheng C, Kilkenny AE, Roop D and Yuspa SH: The v-ras oncogene inhibits the expression of differentiation markers and facilitates expression of cytokeratins 8 and 18 in mouse keratinocytcs. Mol Carcinog 3: 363-373, 1990.
68. Kronenberg MS and Clark JH: Changes in keratin expression during the estrogen-mediated differentiation of rat vaginal epithelium. Endocrinology 117: 1480-1489, 1985.
69. Hsieh JT, Zhau HE, Wang XH, Liew CC and Chung LW: Regulation of basal and luminal cell-specific cytokeratin expression in rat accessory sex organs. Evidence for a new class of androgen-repressed genes and insight into their pairwise control. J Biol Chem 267: 2303-2310, 1992.
70. Coutts AS, Davie JR, Dotzlaw H and Murphy LC: Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem 63: 174-184, 1996.
71. Durfee T, Mancini MA, Jones D, Elledge SJ and Lee W-H: The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol 127: 609-622, 1994.
72. Bassim Hassan A, Errington RJ, White NS, Jackson DA and Cook PR: Replication and transcription sites are colocalized in human cells. J Cell Sci 107: 425-434, 1994.
73. Xing YG, Johnson CV, Moen PT Jr, McNeil JA and Lawrence JB: Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains. J Cell Biol 131: 1635-1647, 1995.
74. Forrester WC, van Genderen C, Jenuwein T and Grosschedl R: Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science 265: 1221-1225, 1994.
75. Jackson DA, Iborra FJ, Manders EMM and Cook PR: Numbers and organization of RNA polymerases, nascent transcripts, and transcription units in HeLa nuclei. Mol Biol Cell 9: 1523-1536, 1998.
76. Misteli T, Caceres JF and Spector DL: The dynamics of a pre-mRNA splicing factor in living cells. Nature 387: 523-527, 1997.
77. Jackson DA and Pombo A: Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J Cell Biol 140: 1285-1295, 1998.
78. Mortillaro MJ, Blencowe BJ, Wei XY, Nakayasu H, Du L, Warren SL, Sharp PA and Berezney R: A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci USA 93: 8253-8257, 1996.
79. He DC, Nickerson JA and Penman S: Core filaments of the nuclear matrix. J Cell Biol 110: 569-580, 1990.
80. Belgrader P, Siegel AJ and Berezney R: A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix. J Cell Sci 98: 281-291, 1991.
81. Sun J-M, Chen HY and Davie JR: Nuclear factor 1 is a component of the nuclear matrix. J Cell Biochem 55: 252-263, 1994.
82. Georgatos SD: Towards an understanding of nuclear morphogenesis. J Cell Biochem 55: 69-76, 1994.
83. Jackson DA and Cook PR: Visualization of a filamentous nucleoskeleton with a 23 nm axial repeat. EMBO J 7: 3667-3677, 1988.
84. Pienta KJ, Getzenberg RH and Coffey DS: Cell structure and DNA organization. Crit Rev Eukaryot Gene Expr 1: 355-385, 1991.
85. Getzenberg RH and Coffey DS: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol Endocrinol 4: 1336-1342, 1990.
86. Fey EG and Penman S: Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci USA 85: 121-125, 1988.
87. Dworetzky SI, Fey EG, Penman S, Lian JB, Stein JL and Stein GS: Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci USA 87: 4605-4609, 1990.
88. Stuurman N, Meijne AM, van der Pol AJ, de Jong L, van Driel R and van Renswoude J: The nuclear matrix from cells of different oricin. Evidence for a common set of matrix proteins. J Biol Chem 265: 5460-5465, 1990.
89. Stuurman N, van Driel R, de Jong L, Meijne AM and van Renswoude J: The protein composition of the nuclear matrix of murine P19 embryonal carcinoma cells is differentiation-stage dependent. Exp Cell Res 180: 460-466, 1989.
90. Berezney R, Basler J, Hughes BB and Kaplan SC: Isolation and characterization of the nuclear matrix from Zajdela ascites hepatoma cells. Cancer Res 39: 3031-3039, 1979.
91. Getzenberg RH, Pienta KJ, Huang EY and Coffey DS: Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res 51: 6514-6520, 1991.
92. Bidwell JP, Fey EG, van Wijnen AJ, Penman S, Stein JL, Lian JB and Stein GS: Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res 54: 28-32, 1994.
93. Bidwell J, van Wijnen A, Banerjee C, Fey E, Merriman H, Penman S, Stein J, Lian J and Stein G: Parathyroid-responsive modifications in the nuclear matrix of ROS 17/2.8 rat osteosarcoma cells. Endocrinology 134: 1738-1744, 1994.
94. Replogle-Schwab TS, Pienta KJ and Getzenberg RH: The utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 6: 103-113, 1996.
95. Samuel SK, Minish TM and Davie JR: Altered nuclear matrix protein profiles in oncogene transformed fibroblasts exhibiting high metastatic potential. Cancer Res 57: 147-151, 1997.
96. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G and Grecnberg AH: Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotypc in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7: 830-837, 1987.
97. 1, (Ser 223, 225). EMBO J 11: 1599-1605, 1992.
98. 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 123:749-758, 1993.
99. Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH and Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202-205, 1987.
100. Fischer AH, Chadee DN, Wright JA, Gansler TS and Davie JR: Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway. J Cell Biochem 70: 130-140, 1998.
101. Ernster VL, Barclay J, Kerlikowske K, Grady D and Henderson C: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913-918, 1996.
102. Kuller LH: The etiology of breast cancer - from epidemiology to prevention. Public Health Rev 23: 157-213, 1995.
103. Leonessa F, Boulay V, Wright A, Thompson EW, Brunner N and Clarke R: The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs. Acta Oncol 31:115-123, 1992.
104. Ruiz Cabello J, Berghmans K, Kaplan O, Lippman ME, Clarke R and Cohen JS: Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies. Breast Cancer Res Treat 33: 209-217, 1995.
105. Godolphin W, Elwood JM and Spinelli JJ: Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer 28: 677-683, 1981.
106. Aamdal S, Bormer O, Jorgensen O, Host H, Eilassen G, Kaalhus O and Pihl A: Estrogen receptor and long term prognosis in breast cancer. Cancer 53: 2525-2529, 1984.
107. McGuire WL, Clark GM, Dressier LG and Owens MA: Role of steroid hormone receptors as prognostic factors in primary breast cancer. Natl Cancer Inst Monogr 1: 19-23, 1986.
108. Clarke R, Dickson RB and Brunner N: The process of malignant progression in human breast cancer. Ann Oncol 1: 401-407 1990.
109. Raymond WA and Leong AS: Co-expression of cytokeratin and vimentin intermediate filament proteins in benicn and neoplastic breast epithelium. J Pathol 157: 299-306, 1989.
110. Raymond WA and Leong AS: Vimentin - a new prognostic parameter in breast carcinoma? J Pathol 158: 107-114, 1989.
111. Miller TE, Beausang LA, Winchell LF and Lidgard GP: Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 52: 422-427, 1992.
112. Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm DL, Lange PH, Messing EM, Pasciak RM, Reservitz GB, Ross RN, Rukstalis DB, Sarosdy MF, Soloway MS, Thiel RP, Vogelzang N and Hayden CL: Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. J Urol 156: 1280-1285, 1996.
113. Samuel SK, Minish MM and Davie JR: Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines. J Cell Biochem 66:9-15, 1997.
114. Khanuja PS, Lehr JE, Soûle HD, Gehani SK, Noto AC, Choudhury S, Chen R and Pienta KJ: Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53: 3394-3398, 1993.
115. Davie JR, Samuel S, Spencer V, Bajno L, Sun J-M, Chen HY and Holth LT: Nuclear matrix: application to diagnosis of cancer and role in transcription and modulation of chromatin structure. Gene Ther Mol Biol 1: 509-528, 1998.
116. Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, Lawrence JB, Penman S, Hiebert S, Lian JB, van Wijnen AJ, Stein JL and Stein GS: Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 95: 1585-1589, 1998.
117. Michelotti EF, Michelotti GA, Aronsohn AI and Levens D: Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol 16: 2350-2360, 1996.
118. Oesterreich S, Lee AV, Sullivan TM, Samuel SK, Davie JR and Fuqua SAW: A novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter. J Cell Biochem 67:275-286, 1997.
119. Blencowe BJ, Issner R, Nickerson JA and Sharp PA: A coactivator of pre-mRNA splicing. Genes Dev 12: 996-1009, 1998.
120. Dunham SU and Lippard SJ: DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modificd DNA. Biochemistry 36: 11428-11436, 1997.
121. Mymryk JS, Zaniewski E and Archer TK: Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo. Proc Natl Acad Sci USA 92: 2076-2080, 1995.
122. Annunziato AT and Scale RL: Histone deacetylation is required for the maturation of newly replicated chromatin. J Biol Chem 258: 12675-12684, 1983.
123. Roth SY and Allis CD: Histone acetylation and chromatin assembly: a single escort, multiple dances. Cell 87: 5-8, 1996.
124. Hebbes TR, Clayton AL, Thorne AW and Crane-Robinson C: Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken β-globin chromosomal domain. EMBO J 13: 1823-1830, 1994.
125. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN and Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389, 1998.
126. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J and Wolffe AP: Methylated DNA and McCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191, 1998.
127. Weitzel JM, Buhrmester H and Stratling WH: Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol Cell Biol 17: 5656-5666, 1997.
128. Mancini MA, Shan B, Nickerson JA, Penman S and Lee W-H: The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci USA 91: 418-422, 1994.
129. Luo RX, Postigo AA and Dean DC: Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473, 1998.
130. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601, 1998.
131. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalcn F, Trouche D and Harel-Bellan A: Retinoblastoma protein represses transcription by recruiting a histone deacetylasc. Nature 391: 601-605, 1998.
132. Mello MLS and Chambers AF: Image analysis of feulgen-stained transformed NIH 3T3 cells differing in p21 expression and metastatic ability. Anal Quant Cytol Histol 16: 113-123, 1994.
133. Chadee DN, Taylor WR, Hurta RAR, Allis CD, Wright JA and Davie JR: Increased phosphorylation of histone H1 in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase kinase. J Biol Chem 270: 20098-20105, 1995.
134. Tan KB, Borun TW, Charpentier R, Cristofalo VJ and Croce CM: Normal and neoplastic human cells have different histone H1 compositions. J Biol Chem 257: 5337-5338, 1982.
135. Laitinen J, Sistonen L, Alitalo K and Holtta E: Cell transformation by c-Ha-rar (val12) oncogene is accompanied by a decrease in histone H10 and an increase in nucleosomal repeat length. J Cell Biochem 57: 1-11, 1994.
136. Roth SY and Allis CD: Chromatin condensation: does histone H1 dephosphorylation play a role? Trends Biochem Sci 17: 93-98, 1992.
137. Lennox RW, Oshima RG and Cohen LH: The H1 histones and their interphase phosphorylated states in differentiated and undifferentiated cell lines derived from murine teratocarcinomas. J Biol Chem 257: 5183-5189, 1982.
138. Taylor WR, Chadee DN, Allis CD, Wright JA and Davie JR: Fibroblasts transformed by combinations of ras, myc and mutant p53 exhibit increased phosphorylation of histone HI that is independent of metastatic potential. FEBS Lett 377: 51-53, 1995.
139. Herrera RE, Chen F and Weinberg RA: Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts. Proc Natl Acad Sci USA 93: 11510-11515, 1996.
140. Chadee DN, Allis CD, Wright JA and Davie JR: Histone H1b phosphorylation is dependent upon ongoing transcription and replication in normal and ras-transformed mouse fibroblasts. J Biol Chem 272: 8113-8116, 1997.
141. Jerzmanowski A and Cole RD: Partial displacement of histone Hl from chromatin is required before it can be phosphorylated by mitotic H1 kinase in vitro. J Biol Chem 267: 8514-8520, 1992.
142. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE and Housman DE: The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14: 33-41, 1996.
143. Reifsnyder C, Lowell J, Clarke A and Pillus L: Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions arc homologous with acetyltransferases. Nat Genet 14:42-49, 1996.
144. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegclberger B, Housman D, Doggett NA, Rowley JD and Zelcznik-Le NJ: MLL is fused to CBP, a histone acetyl-transferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 94: 8732-8737, 1997.
145. Carapeti M, Aguiar RC, Goldman JM and Cross NC: A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91: 3127-3133, 1998.
146. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S and Pelicci PG: Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391: 815-818, 1998.
147. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr and Evans RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811-814, 1998.
148. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968, 1997.
149. Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricotc M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG and Rose DW: Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 95: 2920-2925, 1998.
150. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ and O'Malley BW: Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52: 141-164, 1997.
151. Beato M and Sánchez-Pacheco A: Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17: 587-609, 1996.
152. Glass CK, Rose DW and Rosenfeld MG: Nuclear receptor coactivalors. Curr Opin Cell Biol 9: 222-232, 1997.
153. Bates NP and Hurst HC: An intron 1 enhancer element mediates oestrosen-induced suppression of ERBB2 expression. Oncogene 15: 473-481, 1997.
154. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA and Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758, 1997.
155. Nichols M, Rientjes JM and Stewart AF: Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J 17: 765-773, 1998.
156. Laherty CD, Billin AN, Lavinsky RM, Yochum GS, Bush AC, Sun J-M, Davie JR, Rose DW, Glass CK, Rosenfeld MG, Ayer DE and Eisenman RN: SinAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by a specific subset of transcription factors. Mol Cell (In press).
157. Porter W, Saville B, Hoivik D and Safe S: Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11: 1569-1580, 1997.
158. Nardulli AM, Greene GL and Shapiro DJ: Human estrogen receptor bound to an estrogen response element bends DNA. Mol Endocrinol 7: 331-340, 1993.
159. Wood JR, Greene GL and Nardulli AM: Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 18: 1927-1934, 1998.
160. Furlow JD, Murdoch FE and Gorski J: High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J Biol Chem 268: 12519-12525, 1993.
161. Sewack GF and Hansen U: Nucleosome positioning and transcription-associated chromatin alterations on the human estrogenresponsive pS2 promoter. J Biol Chem 272: 31118-31129, 1997.
162. Kladde MP, Xu M and Simpson RT: Direct study of DNA-protein interactions in repressed and active chromatin in living cells. EMBO J 15: 6290-6300, 1996.
163. Wrenn CK and Katzenellenbogen BS: Cross-linking of estrogen receptor to chromatin in intact MCF-7 human breast cancer cells: optimization and effect of ligand. Mol Endocrinol 4: 1647-1654, 1990.
164. Krishnan V, Wang X and Safe S; Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269: 15912-15917, 1994.
165. Duan R, Porter W and Safe S: Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrocen receptor Sp1 complex formation. Endocrinology 139:1981-1990, 1998.
166. Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N and Fontana JA: Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55: 4999-5006, 1995.
167. Porter W, Wang F, Wang WL, Duan RQ and Safe S: Role of estrogen Receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10: 1371-1378, 1996.
168. Dubik D and Shiu RP: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992.
169. Miller TL, Jin Y, Sun J-M, Coutts AS, Murphy LC and Davie JR: Analysis of human breast cancer nuclear proteins binding to the promoter elements of the